Cargando…
MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression
The poor progress of immunotherapy on osteosarcoma patients requires deeper delineation of immune tolerance mechanisms in the osteosarcoma microenvironment and a new therapeutic strategy. Clearance of apoptotic cells by phagocytes, a process termed “efferocytosis,” is ubiquitous in tumors and mediat...
Autores principales: | Lin, Jinti, Xu, Ankai, Jin, Jiakang, Zhang, Man, Lou, Jianan, Qian, Chao, Zhu, Jian, Wang, Yitian, Yang, Zhengming, Li, Xiumao, Yu, Wei, Liu, Bing, Tao, Huimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757471/ https://www.ncbi.nlm.nih.gov/pubmed/35036076 http://dx.doi.org/10.1080/2162402X.2021.2024941 |
Ejemplares similares
-
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
por: Kim, Jung Eun, et al.
Publicado: (2017) -
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer
por: Myers Chen, Kayla V., et al.
Publicado: (2023) -
CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
por: Jin, Jiakang, et al.
Publicado: (2021) -
Harnessing MerTK agonism for targeted therapeutics
por: Kedage, Vivekananda, et al.
Publicado: (2019) -
Differential polarization and the expression of efferocytosis receptor MerTK on M1 and M2 macrophages isolated from coronary artery disease patients
por: Mohd Idrus, Fatin Najiah, et al.
Publicado: (2021)